Usefulness of heart rate to predict cardiac events in treated patients with high-risk systemic hypertension

Stevo Julius, Paolo Palatini, Sverre E. Kjeldsen, Alberto Zanchetti, Michael A. Weber, Gordon T. McInnes, Hans R. Brunner, Giuseppe Mancia, M. Anthony Schork, Tsushung A. Hua, Bjoern Holzhauer, Dion Zappe, Silja Majahalme, Kenneth Jamerson, Nevres Koylan

Research output: Contribution to journalArticle

65 Citations (Scopus)

Abstract

A high heart rate (HR) predicts future cardiovascular events. We explored the predictive value of HR in patients with high-risk hypertension and examined whether blood pressure reduction modifies this association. The participants were 15,193 patients with hypertension enrolled in the Valsartan Antihypertensive Long-term Use Evaluation (VALUE) trial and followed up for 5 years. The HR was assessed from electrocardiographic recordings obtained annually throughout the study period. The primary end point was the interval to cardiac events. After adjustment for confounders, the hazard ratio of the composite cardiac primary end point for a 10-beats/min of the baseline HR increment was 1.16 (95% confidence interval 1.12 to 1.20). Compared to the lowest HR quintile, the adjusted hazard ratio in the highest quintile was 1.73 (95% confidence interval 1.46 to 2.04). Compared to the pooled lower quintiles of baseline HR, the annual incidence of primary end point in the top baseline quintile was greater in each of the 5 study years (all p

Original languageEnglish
Pages (from-to)685-692
Number of pages8
JournalThe American Journal of Cardiology
Volume109
Issue number5
DOIs
Publication statusPublished - Mar 1 2012

Fingerprint

Heart Rate
Hypertension
Valsartan
Confidence Intervals
Antihypertensive Agents
Blood Pressure
Incidence

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Julius, S., Palatini, P., Kjeldsen, S. E., Zanchetti, A., Weber, M. A., McInnes, G. T., ... Koylan, N. (2012). Usefulness of heart rate to predict cardiac events in treated patients with high-risk systemic hypertension. The American Journal of Cardiology, 109(5), 685-692. https://doi.org/10.1016/j.amjcard.2011.10.025

Usefulness of heart rate to predict cardiac events in treated patients with high-risk systemic hypertension. / Julius, Stevo; Palatini, Paolo; Kjeldsen, Sverre E.; Zanchetti, Alberto; Weber, Michael A.; McInnes, Gordon T.; Brunner, Hans R.; Mancia, Giuseppe; Schork, M. Anthony; Hua, Tsushung A.; Holzhauer, Bjoern; Zappe, Dion; Majahalme, Silja; Jamerson, Kenneth; Koylan, Nevres.

In: The American Journal of Cardiology, Vol. 109, No. 5, 01.03.2012, p. 685-692.

Research output: Contribution to journalArticle

Julius, S, Palatini, P, Kjeldsen, SE, Zanchetti, A, Weber, MA, McInnes, GT, Brunner, HR, Mancia, G, Schork, MA, Hua, TA, Holzhauer, B, Zappe, D, Majahalme, S, Jamerson, K & Koylan, N 2012, 'Usefulness of heart rate to predict cardiac events in treated patients with high-risk systemic hypertension', The American Journal of Cardiology, vol. 109, no. 5, pp. 685-692. https://doi.org/10.1016/j.amjcard.2011.10.025
Julius, Stevo ; Palatini, Paolo ; Kjeldsen, Sverre E. ; Zanchetti, Alberto ; Weber, Michael A. ; McInnes, Gordon T. ; Brunner, Hans R. ; Mancia, Giuseppe ; Schork, M. Anthony ; Hua, Tsushung A. ; Holzhauer, Bjoern ; Zappe, Dion ; Majahalme, Silja ; Jamerson, Kenneth ; Koylan, Nevres. / Usefulness of heart rate to predict cardiac events in treated patients with high-risk systemic hypertension. In: The American Journal of Cardiology. 2012 ; Vol. 109, No. 5. pp. 685-692.
@article{fe1a2ed2129c4a8283a08bcf119728f6,
title = "Usefulness of heart rate to predict cardiac events in treated patients with high-risk systemic hypertension",
abstract = "A high heart rate (HR) predicts future cardiovascular events. We explored the predictive value of HR in patients with high-risk hypertension and examined whether blood pressure reduction modifies this association. The participants were 15,193 patients with hypertension enrolled in the Valsartan Antihypertensive Long-term Use Evaluation (VALUE) trial and followed up for 5 years. The HR was assessed from electrocardiographic recordings obtained annually throughout the study period. The primary end point was the interval to cardiac events. After adjustment for confounders, the hazard ratio of the composite cardiac primary end point for a 10-beats/min of the baseline HR increment was 1.16 (95{\%} confidence interval 1.12 to 1.20). Compared to the lowest HR quintile, the adjusted hazard ratio in the highest quintile was 1.73 (95{\%} confidence interval 1.46 to 2.04). Compared to the pooled lower quintiles of baseline HR, the annual incidence of primary end point in the top baseline quintile was greater in each of the 5 study years (all p",
author = "Stevo Julius and Paolo Palatini and Kjeldsen, {Sverre E.} and Alberto Zanchetti and Weber, {Michael A.} and McInnes, {Gordon T.} and Brunner, {Hans R.} and Giuseppe Mancia and Schork, {M. Anthony} and Hua, {Tsushung A.} and Bjoern Holzhauer and Dion Zappe and Silja Majahalme and Kenneth Jamerson and Nevres Koylan",
year = "2012",
month = "3",
day = "1",
doi = "10.1016/j.amjcard.2011.10.025",
language = "English",
volume = "109",
pages = "685--692",
journal = "American Journal of Cardiology",
issn = "0002-9149",
publisher = "Elsevier Inc.",
number = "5",

}

TY - JOUR

T1 - Usefulness of heart rate to predict cardiac events in treated patients with high-risk systemic hypertension

AU - Julius, Stevo

AU - Palatini, Paolo

AU - Kjeldsen, Sverre E.

AU - Zanchetti, Alberto

AU - Weber, Michael A.

AU - McInnes, Gordon T.

AU - Brunner, Hans R.

AU - Mancia, Giuseppe

AU - Schork, M. Anthony

AU - Hua, Tsushung A.

AU - Holzhauer, Bjoern

AU - Zappe, Dion

AU - Majahalme, Silja

AU - Jamerson, Kenneth

AU - Koylan, Nevres

PY - 2012/3/1

Y1 - 2012/3/1

N2 - A high heart rate (HR) predicts future cardiovascular events. We explored the predictive value of HR in patients with high-risk hypertension and examined whether blood pressure reduction modifies this association. The participants were 15,193 patients with hypertension enrolled in the Valsartan Antihypertensive Long-term Use Evaluation (VALUE) trial and followed up for 5 years. The HR was assessed from electrocardiographic recordings obtained annually throughout the study period. The primary end point was the interval to cardiac events. After adjustment for confounders, the hazard ratio of the composite cardiac primary end point for a 10-beats/min of the baseline HR increment was 1.16 (95% confidence interval 1.12 to 1.20). Compared to the lowest HR quintile, the adjusted hazard ratio in the highest quintile was 1.73 (95% confidence interval 1.46 to 2.04). Compared to the pooled lower quintiles of baseline HR, the annual incidence of primary end point in the top baseline quintile was greater in each of the 5 study years (all p

AB - A high heart rate (HR) predicts future cardiovascular events. We explored the predictive value of HR in patients with high-risk hypertension and examined whether blood pressure reduction modifies this association. The participants were 15,193 patients with hypertension enrolled in the Valsartan Antihypertensive Long-term Use Evaluation (VALUE) trial and followed up for 5 years. The HR was assessed from electrocardiographic recordings obtained annually throughout the study period. The primary end point was the interval to cardiac events. After adjustment for confounders, the hazard ratio of the composite cardiac primary end point for a 10-beats/min of the baseline HR increment was 1.16 (95% confidence interval 1.12 to 1.20). Compared to the lowest HR quintile, the adjusted hazard ratio in the highest quintile was 1.73 (95% confidence interval 1.46 to 2.04). Compared to the pooled lower quintiles of baseline HR, the annual incidence of primary end point in the top baseline quintile was greater in each of the 5 study years (all p

UR - http://www.scopus.com/inward/record.url?scp=84857626451&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84857626451&partnerID=8YFLogxK

U2 - 10.1016/j.amjcard.2011.10.025

DO - 10.1016/j.amjcard.2011.10.025

M3 - Article

C2 - 22169130

AN - SCOPUS:84857626451

VL - 109

SP - 685

EP - 692

JO - American Journal of Cardiology

JF - American Journal of Cardiology

SN - 0002-9149

IS - 5

ER -